Effect of ketorolac tromethamine on bleeding and on requirements for analgesia after total knee arthroplasty.
Dodenhoff
R M
RM
D000700:Analgesics / Q000009:adverse effects*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D004357:Drug Synergism; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects; D020911:Ketorolac Tromethamine; D007720:Knee Prosthesis / Q000009:adverse effects*; D010149:Postoperative Pain / Q000209:etiology / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D019106:Postoperative Hemorrhage / Q000139:chemically induced*; D014046:Tolmetin / Q000009:adverse effects / Q000031:analogs & derivatives*; D014325:Tromethamine / Q000009:adverse effects / Q000031:analogs & derivatives*; D014859:Warfarin / Q000009:adverse effects
D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D006495:Heparin, Low-Molecular-Weight; D010975:Platelet Aggregation Inhibitors; D014325:Tromethamine; D020911:Ketorolac Tromethamine; D014859:Warfarin; D014046:Tolmetin; D007213:Indomethacin